All Pathways
GastroenterologyEmergency

Spontaneous Bacterial Peritonitis Management (AASLD 2021)

Spontaneous Bacterial Peritonitis Management (AASLD 2021): Suspected SBP → Diagnostic Paracentesis → SBP Diagnosis → Rule Out Secondary Peritonitis → ⚠️...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected SBP

    Cirrhosis + ascites + (fever, abdominal pain, encephalopathy, renal dysfunction, or leukocytosis)

    1. Action

      Diagnostic Paracentesis

      Perform BEFORE antibiotics if possible

      • Send: cell count with diff, culture (bedside inoculation)
      • Also: protein, albumin, glucose, LDH
      • Blood cultures x2
      • No contraindication if INR or platelets abnormal
      1. Decision

        SBP Diagnosis

        Ascitic fluid PMN ≥250 cells/mm³

        • Culture-positive or culture-negative SBP
        • Monomicrobial non-neutrocytic bacterascites (MNB): +culture, PMN <250
        1. Decision

          Rule Out Secondary Peritonitis

          Runyon's criteria (≥2 of 3)

          • Ascitic protein >1 g/dL
          • Glucose <50 mg/dL
          • LDH > upper limit of serum
          • Polymicrobial culture
          • If suspected: CT abdomen, surgical consult
          1. Warning

            ⚠️ Secondary Peritonitis

            Urgent surgical evaluation

            • Broad-spectrum antibiotics
            • CT abdomen/pelvis
            • Surgical source control
          2. Action

            Empiric Antibiotic Therapy

            Start immediately after paracentesis

            • Cefotaxime 2g IV q8h (preferred)
            • OR Ceftriaxone 2g IV q24h
            • Duration: 5 days (can extend to 7-10)
            • Avoid aminoglycosides (nephrotoxicity)
            1. Action

              IV Albumin (HRS Prevention)

              Required if Cr >1 or BUN >30 or bilirubin >4

              • 1.5 g/kg on Day 1
              • 1.0 g/kg on Day 3
              • Reduces HRS and mortality by 60%+
              • Consider for all hospitalized SBP
              1. Decision

                48-Hour Reassessment

                Repeat paracentesis if no improvement

                • PMN should decrease by ≥25%
                • Clinical improvement expected
                1. Action

                  Clinical Improvement

                  Continue antibiotics for 5 days total

                  • Switch to PO if able (fluoroquinolone)
                  • No repeat paracentesis needed if improving
                  1. Action

                    Secondary Prophylaxis

                    After SBP episode, lifelong unless transplanted

                    • Norfloxacin 400mg PO daily (preferred)
                    • OR TMP-SMX DS daily
                    • OR Ciprofloxacin 500mg daily
                    • Also primary prophylaxis if: protein <1.5 + (Cr >1.2 OR Na <130 OR Child C)
                    1. Outcome

                      SBP Resolved

                      Continue prophylaxis, optimize cirrhosis management

                    2. Outcome

                      Transplant Evaluation

                      SBP indicates decompensated cirrhosis - MELD exception

                2. Warning

                  Treatment Failure

                  Repeat paracentesis, broaden antibiotics

                  • Consider resistant organisms (ESBL, VRE)
                  • Piperacillin-tazobactam or carbapenem
                  • Re-evaluate for secondary peritonitis
                  • Consider fungal infection

Guideline Source

AASLD Practice Guidance on Ascites, Hepatorenal Syndrome, and SBP 2021

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Antibiotic choice should consider local resistance patterns
  • Secondary bacterial peritonitis requires surgical evaluation
  • HRS prevention requires early albumin
  • Long-term prophylaxis indications evolving

Applicable Regions

USEUGlobal

EU: EASL guidelines are similar

US: AASLD 2021 is current standard

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Spontaneous Bacterial Peritonitis Management (AASLD 2021)?

The Spontaneous Bacterial Peritonitis Management (AASLD 2021) is a emergency clinical algorithm for Gastroenterology. It provides a structured decision tree to guide clinical decision-making, based on AASLD Practice Guidance on Ascites, Hepatorenal Syndrome, and SBP 2021.

What guideline is the Spontaneous Bacterial Peritonitis Management (AASLD 2021) based on?

This algorithm is based on AASLD Practice Guidance on Ascites, Hepatorenal Syndrome, and SBP 2021 (DOI: 10.1002/hep.32327).

What are the limitations of the Spontaneous Bacterial Peritonitis Management (AASLD 2021)?

Known limitations include: Antibiotic choice should consider local resistance patterns; Secondary bacterial peritonitis requires surgical evaluation; HRS prevention requires early albumin; Long-term prophylaxis indications evolving. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Spontaneous Bacterial Peritonitis Management (AASLD 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free